J. Ohmori

发表

Effects of YM-43611, a Novel Dopamine D2-Like Receptor Antagonist, on Immediate Early Gene Expression in the Rat Forebrain

M. Narita, K. Kurokawa, K. Satoh, 1997, Neuropsychopharmacology.

Dopamine D4-like binding sites labeled by [3H]nemonapride include substantial serotonin 5-HT2A receptors in primate cerebral cortex.

M. Matsumoto, K. Hidaka, T. Yamaguchi, 1999, Biochemical and biophysical research communications.

YM90K: pharmacological characterization as a selective and potent alpha-amino-3-hydroxy-5-methylisoxazole-4-propionate/kainate receptor antagonist.

S. Usuda, M. Okada, S. Sakamoto, 1996, The Journal of pharmacology and experimental therapeutics.

8-(1H-imidazol-1-yl)-7-nitro-4(5H)-imidazo[1,2-alpha]quinoxalinone and related compounds: synthesis and structure-activity relationships for the AMPA-type non-NMDA receptor.

M. Okada, S. Sakamoto, M. Shimizu‐Sasamata, 1997, Journal of medicinal chemistry.

In vitro pharmacological profile of YM‐43611, a novel D2‐like receptor antagonist with high affinity and selectivity for dopamine D3 and D4 receptors

S. Usuda, M. Matsumoto, K. Hidaka, 1996, British journal of pharmacology.

6-(1H-imidazol-1-yl)-7-nitro-2,3(1H,4H)-quinoxalinedione hydrochloride (YM90K) and related compounds: structure-activity relationships for the AMPA-type non-NMDA receptor.

T. Furuya, K. Hidaka, M. Okada, 1994, Journal of medicinal chemistry.

Novel 5-hydroxytryptamine (5-HT3) receptor antagonists. II. Synthesis and structure-activity relationships of 4,5,6,7-tetrahydro-1H-benzimidazole derivatives.

T. Suzuki, T. Furuya, K. Miyata, 1996, Chemical & pharmaceutical bulletin.

Novel AMPA receptor antagonists: synthesis and structure-activity relationships of 1-hydroxy-7-(1H-imidazol-1-yl)-6-nitro-2,3(1H,4H)- quinoxalinedione and related compounds.

M. Okada, S. Sakamoto, M. Shimizu‐Sasamata, 1996, Journal of medicinal chemistry.

Novel AMPA Receptor Antagonists: Synthesis and Structure-Activity Relationships of 1-Hydroxy-7-(1H-imidazol-1-yl)-6-nitro-2,3(1H,4H) quinoxalinedione and Related Compounds.

M. Okada, S. Sakamoto, M. Shimizu‐Sasamata, 1997 .

Novel α-Amino-3-hydroxy-5-methylisoxazole-4-propionate Receptor Antagonists: Synthesis and Structure−Activity Relationships of 6-(1H-Imidazol-1-yl)- 7-nitro-2,3(1H,4H)-pyrido[2,3-b]pyrazinedione and Related Compounds

M. Okada, H. Kubota, S. Sakamoto, 1996 .

Novel α-Amino-3-hydroxy-5-methylisoxazole-4-propionate Receptor Antagonists: Synthesis and Structure-Activity Relationships of 6-(1H- Imidazol-1-yl)-7-nitro-2,3(1H,4H)-pyrido(2,3-b)pyrazinedione and Related Compounds.

M. Okada, H. Kubota, S. Sakamoto, 1996 .

Dopamine D3 and D4 receptor antagonists: synthesis and structure--activity relationships of (S)-(+)-N-(1-Benzyl-3-pyrrolidinyl)-5-chloro-4- [(cyclopropylcarbonyl) amino]-2-methoxybenzamide (YM-43611) and related compounds.

S. Usuda, T. Mase, M. Matsumoto, 1996, Journal of medicinal chemistry.

8-(1H-imidazol-1-yl)-7-nitro-4(5H)-imidazo[1,2-alpha]quinoxalinone and related compounds: synthesis and structure-activity relationships for the AMPA-type non-NMDA receptor.

M. Okada, S. Sakamoto, M. Shimizu‐Sasamata, 1997, Journal of medicinal chemistry.